Effects of Whey Protein and Resistance Training on Muscle Mass in Patients With Intestinal Failure
Effect of Whey Protein Supplementation Combined With Resistance Training on Muscle Mass in Patients With Intestinal Failure: A Randomized Controlled Trial
1 other identifier
interventional
72
0 countries
N/A
Brief Summary
This single-center, prospective, four-arm randomized controlled trial will enroll 72 adults with chronic intestinal failure and low muscle mass. All participants will receive standardized basic nutritional support and will be randomly assigned to one of four groups: usual care, whey protein supplementation, resistance training, or whey protein supplementation combined with resistance training. Participants assigned to whey protein supplementation will receive 20 g of whey protein daily for 6 weeks. Participants assigned to resistance training will complete moderate-intensity resistance exercises for approximately 30 minutes, 3 to 5 times per week, for 6 weeks. Participants in the combined group will receive both interventions. Body composition, appendicular skeletal muscle mass index, phase angle, handgrip strength, 6-meter walking speed, laboratory indicators, and quality of life will be assessed at baseline, week 6, and week 8. The study aims to evaluate the effectiveness and safety of whey protein supplementation and resistance training, alone or in combination, for improving muscle mass and physical function in patients with chronic intestinal failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2026
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedStudy Start
First participant enrolled
August 28, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2027
Study Completion
Last participant's last visit for all outcomes
October 28, 2027
August 12, 2026
August 1, 2026
1 year
August 5, 2026
August 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Appendicular Skeletal Muscle Mass Index
Baseline, Week 6, and Week 8
Study Arms (4)
Control Group
NO INTERVENTIONParticipants will receive standardized basic nutritional support and usual clinical care without additional whey protein supplementation or protocol-specified resistance training.
Resistance Training Group
EXPERIMENTALParticipants will receive standardized basic nutritional support and moderate-intensity resistance training for approximately 30 minutes per session, 3 to 5 times per week, for 6 weeks.
Combined Intervention Group
EXPERIMENTALParticipants will receive standardized basic nutritional support, 20 g of whey protein orally once daily, and moderate-intensity resistance training for approximately 30 minutes per session, 3 to 5 times per week, for 6 weeks.
Whey Protein Supplementation Group
EXPERIMENTALInterventions
Participants will receive standardized basic nutritional support and 20 g of whey protein orally once daily for 6 weeks.
Participants will perform moderate-intensity resistance training for approximately 30 minutes per session, 3 to 5 times per week, for 6 weeks, in addition to standardized basic nutritional support.
Eligibility Criteria
You may qualify if:
- Patients with chronic intestinal failure and low muscle mass.
- Willing to participate in the study and provide written informed consent.
- Able to complete the assigned 6-week intervention and the assessments at baseline, week 6, and week 8.
You may not qualify if:
- Known allergy to whey protein.
- Severe renal dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wang Xinyinglead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 5, 2026
First Posted
August 12, 2026
Study Start (Estimated)
August 28, 2026
Primary Completion (Estimated)
August 28, 2027
Study Completion (Estimated)
October 28, 2027
Last Updated
August 12, 2026
Record last verified: 2026-08